AU2292600A - Varicella-zoster virus vaccines - Google Patents

Varicella-zoster virus vaccines

Info

Publication number
AU2292600A
AU2292600A AU22926/00A AU2292600A AU2292600A AU 2292600 A AU2292600 A AU 2292600A AU 22926/00 A AU22926/00 A AU 22926/00A AU 2292600 A AU2292600 A AU 2292600A AU 2292600 A AU2292600 A AU 2292600A
Authority
AU
Australia
Prior art keywords
varicella
zoster virus
virus vaccines
vaccines
zoster
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22926/00A
Inventor
Alex Bollen
Michele Haumont
Paul Jacobs
Alain Jacquet
Marc Georges Francis Massaer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU2292600A publication Critical patent/AU2292600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU22926/00A 1999-01-20 2000-01-17 Varicella-zoster virus vaccines Abandoned AU2292600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9901254 1999-01-20
GBGB9901254.4A GB9901254D0 (en) 1999-01-20 1999-01-20 Vaccines
PCT/EP2000/000352 WO2000043527A1 (en) 1999-01-20 2000-01-17 Varicella-zoster virus vaccines

Publications (1)

Publication Number Publication Date
AU2292600A true AU2292600A (en) 2000-08-07

Family

ID=10846213

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22926/00A Abandoned AU2292600A (en) 1999-01-20 2000-01-17 Varicella-zoster virus vaccines

Country Status (5)

Country Link
AR (1) AR027484A1 (en)
AU (1) AU2292600A (en)
CO (1) CO5241364A1 (en)
GB (1) GB9901254D0 (en)
WO (1) WO2000043527A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
AU2012213948B2 (en) * 2005-03-03 2016-01-21 Glaxosmithkline Biologicals S.A. Vaccine
KR20100063030A (en) * 2007-07-19 2010-06-10 노바백스, 인코포레이티드 Varicella zoster virus-virus like particles (vlps) and antigens
EP2670443A4 (en) * 2011-01-31 2015-10-14 Univ Pennsylvania Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
KR101723605B1 (en) * 2014-10-21 2017-04-07 진원생명과학 주식회사 Dna vaccine composition for preventing and treating herpes zoster and method of activating t-cell to vzv antizen by using the same
KR102028463B1 (en) 2016-11-25 2019-10-04 재단법인 목암생명과학연구소 Varicella Zoster Virus Vaccines
WO2018097642A1 (en) * 2016-11-25 2018-05-31 재단법인 목암생명과학연구소 Varicella zoster virus vaccine
CN112142828B (en) * 2019-06-28 2022-02-01 怡道生物科技(苏州)有限公司 gE gene and vector for expressing the gene
AU2020403296A1 (en) * 2019-12-13 2022-07-07 Grand Theravac Life Science (Nanjing) Co., Ltd. Immunostimulatory composition and use thereof
CN115819616A (en) * 2021-07-28 2023-03-21 江苏瑞科生物技术股份有限公司 Gene recombination VZV fusion protein and preparation method and application thereof
CA3238370A1 (en) 2021-11-24 2023-06-01 Flagship Pioneering Innovations Vi, Llc Varicella-zoster virus immunogen compositions and their uses
CN114891830B (en) * 2022-04-02 2024-03-01 武汉博沃生物科技有限公司 Recombinant expression vector based on varicella-zoster virus, recombinant virus and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0405867B1 (en) * 1989-06-27 1995-03-15 SMITHKLINE BEECHAM BIOLOGICALS s.a. Novel compounds
GB9226768D0 (en) * 1992-12-23 1993-02-17 Smithkline Beecham Biolog Vaccines
GB9413751D0 (en) * 1994-07-07 1994-08-24 British Bio Technology Immunodominant peptides
DE69738597T2 (en) * 1996-02-09 2008-07-24 Glaxosmithkline Biologicals S.A. VAKZINE AGAINST THE VARICELLA ZOSTERVIRUS PRODUCT OF GEN 63

Also Published As

Publication number Publication date
AR027484A1 (en) 2003-04-02
GB9901254D0 (en) 1999-03-10
WO2000043527A1 (en) 2000-07-27
CO5241364A1 (en) 2003-01-31

Similar Documents

Publication Publication Date Title
GB2337755B (en) Virus vaccine
HK1064958A1 (en) Vaccine against hpv
HUP0202885A3 (en) Vaccines
IL145043A0 (en) Vaccine
HUS1300072I1 (en) Vaccine
AU2292600A (en) Varicella-zoster virus vaccines
AUPP967999A0 (en) Viral variants
AU5977700A (en) Vaccines
AU1600401A (en) Malaria vaccine
AU6158700A (en) Vaccine
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
AU4957800A (en) Vaccine against isa virus
GB9925432D0 (en) Virus preparation
GB9906437D0 (en) Vaccine
AU5811600A (en) Vaccine
AU5084300A (en) New vaccine formulations - 1
GB9930585D0 (en) Component for vaccine
AU4935700A (en) New vaccine formulations-3
GB9925434D0 (en) Virus Preparation
GB9917981D0 (en) Viral vaccine
GB9909072D0 (en) Vaccine
GB9909466D0 (en) Vaccines
GB9904048D0 (en) Vaccines
GB9904280D0 (en) Vaccines
SI1155119T1 (en) Bhv-1 gene-deleted virus vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase